As BioWorld Insight readers know, our “Word on the Street” column provides a sample of the most entertaining and thought-provoking quotes our staff stumbles upon each week. Some are gathered during interviews, some gleaned from analyst reports, and some overheard…
How old is our clinical trial system?
It looked Monday as if two of biotech’s long-suffering names might finally be biting the dust.
Racial profiling – long in the realm of bad law enforcement – was criticized as bad medicine, too, in a recent paper by scientists from the Mount Sinai School of Medicine.
Recruiting subjects for ongoing Phase III hepatitis C virus (HCV) trials just got a lot harder.
Join the Conversation